摘要
目的分析乙型肝炎病毒携带者及患者的血清前S1抗原(PreS1)与乙肝e抗原(HBeAg)的关系,评价PreS1的临床检测意义。方法筛选1315例门诊和住院治疗的乙型肝炎病毒携带者及患者的血清,采用ELISA法检测PreS1和HBV—M,并对HBeAg检测结果和PreS1检测结果不一致的样本,进一步进行HBV—DNA检测。结果HBsAg阳性标本中,PreS1阳性率为63.5%(835/1315),明显高于HBeAg的阳性率29.3%(385/1315),表明在HBV携带及患病者中,存在着较高的病毒复制。结论PreS1检测比乙肝五项尤其是HBeAg更能反映其体内HBV病毒的复制情况,具有非常重要的临床价值。PreS1作为检测体内病毒存在及繁殖情况的实验室指标,与HBV—M联合检测,对HBV感染者的早期诊断及治疗效果的动态观察具有重要意义。
Objective To analyze relationship between PreSl and HBeAg on hepatitis B virus carriers and patients. Methods Screening of 1315 cases of chronic hepatitis B virus carriers and patients with serum,the plasma levels of PreSl and HBV - M were examined by ELISA, HBV - DNA was examined if the monitoring result of PreS1 inconsistency with HBeAg. Results With the HBsAg positive serum,the positive rate of PreS1 were 63.5% (835/1315), much bighter than the HBeAg positive of 29.3% (385/1315 ). It shows that the virus replication was higher on hepatitis B virus carriers and patients ,and PreSl can accurately reflect the condition of virus replication. Concultion PreS1 can accurately reflect the condition of virus replication, it possess a very important clinical significance.
出处
《中国医学创新》
CAS
2009年第18期3-4,共2页
Medical Innovation of China